4.8 Article

Plasma lipidome reveals critical illness and recovery from human Ebola virus disease

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1815356116

Keywords

lipidomics; Ebola; critical illness; therapies; mass spectrometry

Funding

  1. Health and Labor Sciences Research grant (Japan)
  2. Ministry of Education, Culture, Sports, Science and Technology of Japan [16H06429, 16K21723, 16H06434]
  3. Emerging/Re-Emerging Infectious Diseases Project of Japan
  4. National Institute of Allergy and Infectious Diseases (NIAID), NIH [U19AI106772]
  5. Department of Energy (DOE) Office of Biological and Environmental Research
  6. National Institute of General Medical Sciences Grant [P41 GM103493]
  7. DOE [DE-AC05-76RLO 1830]
  8. Grants-in-Aid for Scientific Research [16H06434] Funding Source: KAKEN

Ask authors/readers for more resources

Ebola virus disease (EVD) often leads to severe and fatal outcomes in humans with early supportive care increasing the chances of survival. Profiling the human plasma lipidome provides insight into critical illness as well as diseased states, as lipids have essential roles as membrane structural components, signaling molecules, and energy sources. Here we show that the plasma lipidomes of EVD survivors and fatalities from Sierra Leone, infected during the 2014-2016 Ebola virus outbreak, were profoundly altered. Focusing on how lipids are associated in human plasma, while factoring in the state of critical illness, we found that lipidome changes were related to EVD outcome and could identify states of disease and recovery. Specific changes in the lipidome suggested contributions from extracellular vesicles, viremia, liver dysfunction, apoptosis, autophagy, and general critical illness, and we identified possible targets for therapies enhancing EVD survival.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available